AzTrials
AzTrials

Deglutition DisorderNCT00001936

Electrical Muscle Stimulation to Aid Swallowing in Dysphagia

An observational study of Deglutition Disorder and Healthy, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the feasibility of using extrinsic laryngeal muscle stimulation to elevate the larynx in a manner similar to that which occurs during normal swallowing. Read more about this study

Who is it for?
Ages Up to 90 yearsHealthy volunteers can take part
Conditions the study is for
Deglutition Disorder, Healthy
How many people
155 participants
Where
1 siteUnited States
Study dates
28 Sep 1999to 18 Aug 2009
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • The normal volunteers will be without cardiac, pulmonary, neurological, otolaryngological, psychiatric or speech, swallowing and hearing problems as determined by medical history and examination by a physician.

Who cannot join

  • For volunteers undergoing either intra-muscular stimulation or submental surface stiimulation:
  • History of Rheumatic fever, mitral valve prolapse, or cardiac arrhythmias as determined by medical history, physical and EKG. A physician will auscultate for cardiac murmurs prior to any study to exclude patients who might be at risk for endocarditis. Subjects will have an EKG as part of the screening for participation in the study.
  • Pregnancy will exclude women from participation because the study involves radiation exposure.
  • Subjects will also be excluded if they are taking psychiatric or neuroleptic medications which would interfere with the interpretation of the neurophysiological studies or are taking herbal medications that can affect coagulation.
  • Subjects with a history of a psychiatric disorder, under the care of a psychiatrist, or on medications for treatment of a psychiatric disorder will be excluded from study. Examples of psychiatric disorders to be excluded are: somatoform disorders, conversion disorders, current major depression, or a history of schizophrenia or a bipolar disorder. However, a history of a previous episode of a minor reactive depression would not exclude a person from participation.
  • Normal volunteers who are pregnant, or have any active medical or psychiatric conditions will not be included for submental surface stimulation, as these may be contraindications.
Show all 34Show fewer
  • For volunteers undergoing intra-muscular stimulation:
  • Subjects will be excluded if they have a history of allergies to lidocaine.
  • Subjects must be HIV negative. HIV testing for out of town participants may be done prior to traveling to the NIH. This is required because there is no potential benefit for normal volunteers from participation in the study. Because multiple needle insertions are required and the hooked wire electrodes remain in place for 1-2 hours increasing a risk of contamination, persons who are immuno-compromised would be put at undue risk with no opportunity for benefit.
  • None of the normal volunteers will have a reduction in the range of vocal fold movement during the nasoendoscopy that might suggest laryngeal paralysis or paresis, joint abnormality or neoplasm.
  • Caution will be exercised in patients with suspected or diagnosed heart problems or suspected or diagnosed with epilepsy at the discretion of the physician.
  • INCLUSION CRITERIA FOR PATIENTS WITH CHRONIC PHARYNGEAL DYSPHAGIA:
  • No peripheral laryngeal nerve injury that results in a lack of glottic closure for swallowing.
  • No peripheral nerve injury to the muscles that will be stimulated for hyo-laryngeal elevation.
  • No laryngeal trauma that results in a lack of glottic closure for swallowing.
  • Intact cognition and hearing (30 dB HL in speech range); IQ no less than 85.
  • Current dependence on alternate means of nutrition and hydration (PEG, PEJ, PPN/TPN); however, minimal PO is not cause for exclusion.
  • Have stable vital signs before coming to the NIH for study. To determine if a patient has stable vital signs prior to admission and a physician has provided approval for participation, the following information will be required depending upon the location of the patient prior to admission. For patients in a nursing home setting, vital signs will be needed 3 days prior to admission and a written form signed by the physician releasing the patient. For patients not in a nursing home a physician's letter of referral written in the past year documenting that the patient is medically stable will be required and a telephone contact with the family or others involved in the patient's care that the patient is stable before coming to the NIH.
  • At least 6 months post onset.
  • A Mini-Mental State Examination (MMSE) score greater than or equal to 21.
  • Evidence of pharyngeal dysphagia placing the patient at risk for aspiration.
  • Participants may have other health problems such as diabetes mellitus, arteriosclerotic coronary vascular disease and a history of smoking. These will not be cause for automatic exclusion, but will be examined on an individual basis by the otolaryngologist in determining the potential risk and benefit to the individual participant.
  • Patients will have restricted per oral intake. Prior history of tracheostomy or current tracheostomy is not a cause for exclusion.
  • History of progressive neurodigestive disease, amyotrophic lateral sclerosis, etc.
  • History of swallowing difficulties prior to most recent or previous CVA's.
  • Dementia, obtundation, somnolence, and agitation.
  • More than 90 years of age.
  • A tracheostomy that fixes the laryngeal position interfering with the possibility of elevation.
  • Moderate to severe oral phase swallowing dysfunction.
  • Pharyngeal structural abnormalities on videofluoroscopy including mass and diverticulum.
  • Esophageal motility not within normal range of function appropriate for the patient's age.
  • Patient on a regular diet without difficulties.
  • A MMSE score less than or equal to 20.
  • Patients who are pregnant, have a cardiac demand pacemaker, dementia, exhibit non-stop vocalization, significant reflux due to use of a feeding tube, or drug toxicity will not be included for VitalStim, as these are contraindications for use of the device. Caution will be exercised in selection of patients with suspected or diagnosed heart problems or suspected or diagnosed with epilepsy at the discretion of the physician.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, 20892

Other trials in United States

About this study

Official title: Feasibility of Neuromuscular Stimulation for Laryngeal Elevation During Swallowing

The purpose of this study is to determine the feasibility of using extrinsic laryngeal muscle stimulation to elevate the larynx in a manner similar to that which occurs during normal swallowing. This research will also determine whether laryngeal elevation will open the upper esophageal sphincter to assist with entry of the bolus into the esophagus. This protocol includes studies in normal volunteers and patients with swallowing disorders. The outcome of this study will be relevant to future use of neuromuscular stimulation for laryngeal elevation in patients with pharyngeal dysphagia....

Read the detailed description

Objectives:

  1. To determine if stimulation of the extrinsic laryngeal muscles will elevate the larynx.
  2. To determine if augmentation of laryngeal elevation using intra-muscular stimulation will reduce the risk of aspiration in chronic pharyngeal dysphagia.
  3. To determine whether stimulation to induce laryngeal elevation assists with opening the upper esophageal sphincter both at rest and during swallowing.
  4. To determine whether laryngeal sensation is intact has bearing on the ability of patients with chronic dysphagia to trigger the onset of stimulation in synchrony with their own swallowing.
  5. To contrast the effects of surface and intra-muscular stimulation on hyo-laryngeal movement at rest.
  6. To contrast the benefits of surface and intra-muscular stimulation on the risk or aspiration/penetration during swallowing.

Study Population: Both normal volunteers and patients with severe chronic pharyngeal dysphagia.

Design: Hooked wire electrodes and surface electrodes will be used to stimulate extrinsic muscles either alone or in combination both at rest and during swallowing while using videofluoroscopy to record hyo-laryngeal movement.

Outcome Measures: Kinematic analyses of hyo-laryngeal movements using image processing and marking from video-recordings will quantify movement with stimulation, manometric pressure recordings and cricopharyngeus electromyography will evaluate the effects of muscles stimulation on the upper esophageal sphincter function and blinded ratings of the degree of aspiration and penetration and clearance during swallowing will be conducted by speech-language pathologists to compare the effects of intra-muscular and surface stimulation on swallowing on risk of aspiration and penetration during swallowing.

Keywords
Neuromuscular Stimulation, Laryngeal Elevation, Dysphagia, Stroke, Neuroprosthesis, Dysphonia, Aspiration, Motor Control, Videofluoroscopy, Upper Esophageal Sphincter, Healthy Volunteer, Swallowing Disorders
Medical subject headings
Deglutition Disorders, Stroke, Dysphonia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 1999 (estimated)
  2. Study start28 Sep 1999
  3. Primary completion18 Aug 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Enrolment
155 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00001936
Sponsor's protocol ID
990178
Other IDs
99-N-0178
Status last verified
18 Aug 2009
First submitted
3 Nov 1999
Last updated
2 Jul 2017
Results posted
No

Publications

  • Bulow M, Olsson R, Ekberg O. Videomanometric analysis of supraglottic swallow, effortful swallow, and chin tuck in healthy volunteers. Dysphagia. 1999 Spring;14(2):67-72. doi: 10.1007/PL00009589.

    PubMed 10028035
  • Bergmann K, Warzel H, Eckhardt HU, Hopstock U, Hermann V, Gerhardt HJ. Long-term implantation of a system of electrical stimulation of paralyzed laryngeal muscles in dogs. Laryngoscope. 1988 Apr;98(4):455-9. doi: 10.1288/00005537-198804000-00020.

    PubMed 3258397
  • Broniatowski M, Sohn J, Kayali H, Bold EL, Miller FR, Jacobs GB, Tucker HM. Artificial reflex arc: a potential solution for chronic aspiration. III: Stimulation of implanted cervical skin as a functional graft triggering glottic closure in the canine. Laryngoscope. 1994 Oct;104(10):1259-63. doi: 10.1288/00005537-199410000-00013.

    PubMed 7934597

Questions about this trial

What is this clinical trial studying?

An observational study of Deglutition Disorder and Healthy, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 34 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00001936, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in